Alemtuzumab after Natalizumab SWitch in Evolving Rapidly Severe Multiple Sclerosis (ANSWERS MS)

PJ Gallagher, C McGuigan, R Nicholas, J Hobart, H Ford, K Petheram, B Sharrack, N Robertson, G Mazibrada, N Scolding, M Wilson, O Pearson, E Silber, D Rog, B Turner, S Harikrishnan, M Duddy, O Gray, J Jones, J OverellMS ANSWERS

Research output: Contribution to conferenceConference paper (not formally published)peer-review

Original languageEnglish
DOIs
Publication statusPublished - Oct 2017

Cite this